Clovis Oncology, Inc. (CLVS)
(Delayed Data from NSDQ)
$18.95 USD
+0.51 (2.77%)
Updated May 3, 2019 04:00 PM ET
After-Market: $18.96 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
Estimates
Exp Earnings Date | 2/22/23 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.39 |
Last EPS Surprise | 7.14% |
ABR | 4.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.68 |
Next Year | -0.98 |
EPS (TTM) | -1.75 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2022) |
Next Qtr (3/2023) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 31.40M | 35.74M | 128.46M | 147.43M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 31.40M | 35.74M | 128.46M | 147.43M |
Low Estimate | 31.40M | 35.74M | 128.46M | 147.43M |
Year ago Sales | 35.97M | 34.25M | 148.76M | 128.46M |
Year over Year Growth Est. | -12.71% | 4.35% | -13.64% | 14.77% |
Earnings Estimates
Current Qtr (12/2022) |
Next Qtr (3/2023) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.29 | -1.68 | -0.98 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.35 | -0.29 | -1.68 | -0.98 |
High Estimate | -0.35 | -0.29 | -1.68 | -0.98 |
Low Estimate | -0.35 | -0.29 | -1.68 | -0.98 |
Year ago EPS | -0.49 | -0.44 | -2.27 | -1.68 |
Year over Year Growth Est. | 28.57% | 34.09% | 25.99% | 41.67% |
Agreement - Estimate Revisions
Current Qtr (12/2022) |
Next Qtr (3/2023) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2022) |
Next Qtr (3/2023) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Current | -0.35 | -0.29 | -1.68 | -0.98 |
7 Days Ago | -0.35 | -0.29 | -1.68 | -0.98 |
30 Days Ago | -0.33 | -0.29 | -1.65 | -0.86 |
60 Days Ago | -0.36 | -0.28 | -1.75 | -0.99 |
90 Days Ago | -0.38 | -0.28 | -1.74 | -0.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2022) |
Next Qtr (3/2023) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.29 | -1.68 | -0.98 |
Zacks Consensus Estimate | -0.35 | -0.29 | -1.68 | -0.98 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2022) |
Quarter Ending (6/2022) |
Quarter Ending (3/2022) |
Quarter Ending (12/2021) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.39 | -0.43 | -0.44 | -0.49 | NA |
Estimate | -0.42 | -0.42 | -0.43 | -0.60 | NA |
Difference | 0.03 | -0.01 | -0.01 | 0.11 | 0.03 |
Surprise | 7.14% | -2.38% | -2.33% | 18.33% | 5.19% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more